|
[1]YOUNOSSI ZM, KOENIG AB, ABDELATIF D, et al.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J].Hepatology, 2016, 64 (1) :73-84.
|
|
[2]FAN JG, KIM SU, WONG VW.New trends on obesity and NAFLDin Asia[J].J Hepatol, 2017, 67 (4) :862-873.
|
|
[3]MACHADO MV, OLIVEIRA AG, CORTEZ-PINTO H.Hepatic steatosis in hepatitis B virus infected patients:Meta-analysis of risk factors and comparison with hepatitis C infected patients[J].JGastroenterol Hepatol, 2011, 26 (9) :1361-1367.
|
|
[4]WANG MM, WANG GS, SHEN F, et al.Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors[J].Dig Dis Sci, 2014, 59 (10) :2571-2579.
|
|
[5]PENG D, HAN Y, DING H, et al.Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors[J].J Gastroenterol Hepatol, 2008, 23 (7 Pt 1) :1082-1088.
|
|
[6]CHU CM, LIN DY, LIAW YF.Clinical and virological characteristics post HBs Ag seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without[J].Dig Dis Sci, 2013, 58 (1) :275-281.
|
|
[7]HUI RWH, SETO WK, CHEUNG KS, et al.Inverse relationship between hepatic steatosis and hepatitis B viremia:Results of a large case-control study[J].J Viral Hepat, 2018, 25 (1) :97-104.
|
|
[8]SHI JP, FAN JG, WU R, et al.Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection[J].J Gastroenterol Hepatol, 2008, 23 (9) :1419-1425.
|
|
[9]JIN X, CHEN YP, YANG YD, et al.Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B[J].PLo S One, 2012, 7 (3) :e34198.
|
|
[10]ZHANG ZQ, WANG GS, KANG KF, et al.Prevalence and clinical features of hepatic steatosis in patients with chronic hepatitis B[J].J Clin Hepatol, 2015, 31 (7) :1063-1067. (in Chinese) 张志侨, 王功遂, 康凯夫, 等.慢性乙型肝炎合并非酒精性脂肪性肝病的临床特征分析[J].临床肝胆病杂志, 2015, 31 (7) :1063-1067.
|
|
[11]PAN Q, ZHANG RN, WANG YQ, et al.Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B[J].World J Gastroenterol, 2015, 21 (28) :8605-8614.
|
|
[12]ROMEO S, KOZLITINA J, XING C, et al.Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease[J].Nat Genet, 2008, 40 (12) :1461-1465.
|
|
[13]ESLAM M, MANGIA A, BERG T, et al.Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes[J].Hepatology, 2016, 64 (1) :34-46.
|
|
[14]WONG VW, WONG GL, TSE CH, et al.Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese[J].J Hepatol, 2014, 61 (3) :708-709.
|
|
[15]ZHONG GC, WU YL, HAO FB, et al.Current but not past hepatitis B virus infection is associated with a decreased risk of nonalcoholic fatty liver disease in the Chinese population:A case-control study with propensity score analysis[J].J Viral Hepat, 2018, 25 (7) :842-852.
|
|
[16]JOO EJ, CHANG Y, YEOM JS, et al.Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease:A cohort study[J].Hepatology, 2017, 65 (3) :828-835.
|
|
[17]ENOMOTO H, AIZAWA N, NISHIKAWA H, et al.Relationship between hepatic steatosis and the elevation of aminotransferases in HBV-infected patients with HBe-antigen negativity and a low viral load[J].Medicine (Baltimore) , 2016, 95 (17) :e3565.
|
|
[18]LIN CW, HUANG XL, LIU HL, et al.Interactions of hepatitis Bvirus infection with nonalcoholic fatty liver disease:Possible mechanisms and clinical impact[J].Dig Dis Sci, 2015, 60 (12) :3513-3524.
|
|
[19]LIU SF, WU BR, LIU ZZ, et al.Clinic characteristics of patients with chronic hepatitis B overlapped with non-alcoholic fatty liver diseases[J].J Pract Hepatol, 2015, 18 (5) :540-541. (in Chinese) 刘素芬, 武博荣, 刘振中, 等.非酒精性脂肪性肝病合并HBV感染患者临床特征分析[J].实用肝脏病杂志, 2015, 18 (5) :540-541.
|
|
[20]CHEN Y, FAN C, CHEN Y, et al.Effect of hepatic steatosis on the progression of chronic hepatitis B:A prospective cohort and in vitro study[J].Oncotarget, 2017, 8 (35) :58601-58610.
|
|
[21]LIANG J, CAI W, HAN T, et al.The expression of thymosinβ4 in chronic hepatitis B combined nonalcoholic fatty liver disease[J].Medicine (Baltimore) , 2016, 95 (52) :e5763.
|
|
[22]YANG XZ, GENG AW, XIAO L, et al.Pathological and clinical features of patients with chronic hepatitis B and non-alcoholic fatty liver disease[J].J Pract Hepatol, 2017, 20 (1) :101-102. (in Chinese) 杨秀珍, 耿爱文, 肖丽, 等.慢性乙型肝炎合并脂肪肝临床与肝组织病理学分析[J].实用肝脏病杂志, 2017, 20 (1) :101-102.
|
|
[23]CEYLAN B, ARSLAN F, BATIREL A, et al.Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir[J].Turk J Gastroenterol, 2016, 27 (1) :42-46.
|
|
[24]KARACAER Z.Non-alcoholic fatty liver disease in chronic hepatitis B patients[J].Turk J Gastroenterol, 2016, 27 (4) :395-396.
|
|
[25]ZHANG ZQ, WANG GS, KANG KF, et al.The clinical and pathological features of hepatic steatosis in patients with chronic hepatitis B based on a matched case-control study[J].Chin J Infect Dis, 2016, 34 (3) :146-150. (in Chinese) 张志侨, 王功遂, 康凯夫, 等.基于216对配对病例研究慢性乙型肝炎患者肝脂肪变性的临床和病理特征[J].中华传染病杂志, 2016, 34 (3) :146-150.
|
|
[26]CHEN JN, ZHUANG QY, CHEN BF, et al.The influencing factors of hepatic steatosis in patients with chronic hepatitis B[J].Chin J Infect Dis, 2013, 31 (3) :160-165. (in Chinese) 陈建能, 庄群瑛, 陈碧芬, 等.慢性乙型肝炎合并肝脂肪变的影响因素[J].中华传染病杂志, 2013, 31 (3) :160-165.
|
|
[27]ZHU Y, YANG Q, LV F, et al.The effect of hepatosteatosis on response to antiviral treatment in patients with chronic hepatitis B:Ameta-analysis[J].Gastroenterol Res Pract, 2017, 2017:1096406.
|
|
[28]CHEN J, WANG ML, LONG Q, et al.High value of controlled attenuation parameter predicts a poor antiviral response in patients with chronic hepatits B[J].Hepatobiliary Pancreat Dis Int, 2017, 16 (4) :370-374.
|
|
[29]WU YQ, SHEN LJ, YU JH, et al.Clinical effect of entecavir in treatment of chronic hepatitis B complicated by hepatic steatosis[J].J Clin Hepatol, 2017, 33 (5) :849-852. (in Chinese) 吴艳琴, 沈黎俊, 于集虹, 等.恩替卡韦治疗慢性乙型肝炎合并肝脂肪变的效果评价[J].临床肝胆病杂志, 2017, 33 (5) :849-852.
|
|
[30]GONG L, LIU J, WANG J, et al.Hepatic steatosis as a predictive factor of antiviral effect of pegylated interferon therapy in patients with hepatitis B[J].Transplant Proc, 2015, 47 (10) :2886-2891.
|
|
[31]ZHU LY, ZHOU J, FENG WG, et al.The comparison of the efficacy of entecavir in the treatment of patients with chronic hepatitis Band non-alcoholic fatty liver disease[J].Chin J Infect Dis, 2016, 34 (6) :362-363. (in Chinese) 朱礼尧, 周建, 冯伟广, 等.恩替卡韦治疗单纯慢性乙型肝炎和合并非酒精性脂肪性肝病患者的效果比较[J].中华传染病杂志, 2016, 34 (6) :362-363.
|
|
[32]MI YQ, LIU YG, XU L, et al.The association between hepatic steatosis and HBs Ag and HBc Ag in chronic hepatitis B patients[J].Chin J Dig, 2012, 32 (5) :316-319. (in Chinese) 宓余强, 刘勇钢, 徐亮, 等.慢性乙型肝炎患者肝脂肪变与肝脏HBs Ag和HBc Ag的关系[J].中华消化杂志, 2012, 32 (5) :316-319.
|
|
[33]KARACAER Z, OKUR G, CERMIK H, et al.Is there an influence of hepatic steatosis on fibrosis and necroinflammation in young patients with chronic viral hepatitis B[J].Postgrad Med, 2016, 128 (7) :697-700.
|
|
[34]SETO WK, HUI RWH, MAK LY, et al.Association between hepatic steatosis, measured by controlled attenuation parameter, and fibrosis burden in chronic hepatitis B[J].Clin Gastroenterol Hepatol, 2018, 16 (4) :575-583.
|
|
[35]FAN JG, CHEN GF, JI D, et al.Long-term disease progression in chronic hepatitis B Chinese patients with comorbid nonalcoholic fatty liver disease[J].J Hepatol, 2017, 66 (1) :s416-s417.
|
|
[36]CHAN AW, WONG GL, CHAN HY, et al.Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B[J].J Gastroenterol Hepatol, 2017, 32 (3) :667-676.
|
DownLoad: